Charts

21 Nov, 2022
12:00
Seeking Alpha
17 Nov, 2022
23:14
Seeking Alpha

News

07 Feb, 2106
27 Nov, 2022
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
21 Nov, 2022
Company reports initial ONA-XR data from the ongoing Phase 2 SMILE trial for metastatic breast cancer will be presentedPHILADELPHIA, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing novel treatments for breast and gynecologic cancers, today announced clinical data on onapristone extended release (ONA-XR) will be presented at the 2022 San Antonio Breast Cancer Symposium® (SABCS®) taking place in San Anto
10 Nov, 2022
Context Therapeutics Inc. (NASDAQ: CNTX) and Integral Molecular are teaming up to develop an anti-claudin 6 (CLDN6) bispecific ...
09 Nov, 2022
Company reports preliminary ONA-XR data from two ongoing Phase 2 trials ONA-XR demonstrates preliminary 4-month PFS rate of 77.7% in ongoing Phase 2 trial evaluating the combination of ONA-XR and the antiestrogen anastrozole in PR+ recurrent endometrial cancer ONA-XR continues to exhibit favorable safety and tolerability profile Cash and cash equivalents of $39 million as of September 30, 2022, expected to provide runway into Q1 2024 PHILADELPHIA, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Context Therap
20 Oct, 2022
Philadelphia, Pennsylvania--(Newsfile Corp. - October 20, 2022) - Context Therapeutics Inc. (NASDAQ: CNTX) ("Context" or the "Company"), a women's oncology company developing novel treatments for breast and gynecologic cancers, today announced the Company will participate in The ThinkEquity Conference, taking place on October 26, 2022, at The Mandarin Oriental Hotel in New York City.Context CEO Martin Lehr will present at 9:30 a.m. ET on October 26. Interested parties can register to attend here
27 Sep, 2022
Company to focus resources on advancing ONA-XR ELONA Phase 1b/2 clinical trial and on advancing CLDN6xCD3 bispecific antibody toward INDPHILADELPHIA, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing novel treatments for breast and gynecological cancers, today announced updated cash guidance to extend its runway into Q1 2024. The company plans to defer noncritical R&D activities, reduce future overhead
06 Sep, 2022
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
PHILADELPHIA, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing novel treatments for breast and gynecological cancers, today announced that Chief Executive Officer Martin Lehr will participate in a fireside chat during the H.C. Wainwright 24th Annual Global Investment Conference taking place virtually and in-person September 12-14, 2022, in New York City. The fireside chat will be available on demand fo
17 Aug, 2022
Martin Lehr, Co-Founder and CEO of Contect Therapeutics, Inc (NASDAQ: CNTX), was a guest on Benzinga’s All Access on Aug 12, ...
11 Aug, 2022
Announced new clinical trial collaboration with Menarini Group to evaluate ONA-XR plus elacestrant in metastatic breast cancer Results of the monotherapy portion of Phase 2 ONA-XR clinical trial in granulosa cell tumors of the ovary presented at the 2022 ASCO Annual Meeting Preliminary results from multiple clinical trials planned for Q4 2022 On track for development candidate selection of CLDN6xCD3 bispecific in Q4 2022 PHILADELPHIA, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (
02 Aug, 2022
Context Therapeutics Inc. ("Context" or the "Company") (Nasdaq: CNTX), a women's oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, and The Menarini Group ("Menarini") today announced a clinical trial collaboration and supply agreement for Menarini's oral selective estrogen receptor degrader (SERD), elacestrant.
06 Jun, 2022
09:31
FinancialContent
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers ...
03 Jun, 2022
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it ...
23 May, 2022
07:57
FinancialContent
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 ...
15 May, 2022
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
11 May, 2022
Abstract on results of the monotherapy portion of Phase 2 ONA-XR clinical trial in granulosa cell tumors of the ovary accepted for oral presentation at the 2022 ASCO Annual Meeting Preclinical data presented at AACR Annual Meeting showcased potential of ONA-XR and CLDN6xCD3 bispecific development program PHILADELPHIA, May 11, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treat
05 May, 2022
Lead clinical-stage oral progesterone receptor (PR) antagonist ONA-XR demonstrates monotherapy clinical activity in advanced granulosa cell tumor of the ovary Trial advanced to second stage to evaluate combination of ONA-XR with oral antiestrogen PHILADELPHIA, May 05, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, today announced
11 Apr, 2022
Lead clinical-stage oral progesterone receptor (PR) antagonist ONA-XR demonstrates strong efficacy across multiple PR+ solid tumor models First presentation of preclinical CLDN6xCD3 bispecific antibody optimization, binding properties, and T-cell dependent cytotoxicity Context to host webinar with AACR presenters on Wednesday, April 13, 2022, at 11 a.m. ET PHILADELPHIA, April 11, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology co
06 Apr, 2022
PHILADELPHIA, April 06, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, today announced that Chief Executive Officer Martin Lehr will participate virtually in two investor conferences in April 2022. Details of the events are as follows: Canaccord Genuity's (CG) 2022 Horizons in Oncology Virtual Conference: The Company will present
05 Apr, 2022
10:37
FinancialContent
Gainers GBS Inc. (NASDAQ: GBS) jumped 68% to settle at $1.31 on Monday. Zacks Small-Cap Research issued a note on GBS with an $8 ...
04 Apr, 2022
Gainers Aterian, Inc. (NASDAQ: ATER) shares jumped 43.5% to $3.3457. Aterian said Cynthia Williams has joined the Company's ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you're looking for the biggest pre-market stock movers for Monday, we've got you covered with a list of gainers and losers for today. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Get in Now on Tiny $3 ‘Forever Battery’ Stock It doesn’t matter if you have $500 in savings or $5 million. Do this now. Stock Prodigy Who Found NIO at $2… Says Buy THIS Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
Gainers SPI Energy Co., Ltd. (NASDAQ: SPI) rose 36.3% to $3.87 in pre-market trading after reporting record revenue of $162 ...
23 Mar, 2022
Investor R&D event on April 13th to highlight new preclinical data to be presented at AACR Annual Meeting Strong cash position following $28.75M initial public offering and $31.25M private placement PHILADELPHIA, March 23, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, today announced financial results for the year ended December
08 Mar, 2022
Context to host webinar with AACR presenters on Wednesday, April 13, 2022, at 11 a.m. ETPHILADELPHIA, March 08, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, today announced that five abstracts have been selected for poster or symposium presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022, tak
05 Mar, 2022
22 Feb, 2022
PHILADELPHIA, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, today announced that Chief Executive Officer Martin Lehr will deliver a corporate presentation during the Sachs 15th Annual European Life Sciences CEO Forum taking place virtually March 1-2, 2022. The Company’s presentation will be available for on-demand viewi
02 Feb, 2022
Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure ...
31 Jan, 2022
Photo sourced from Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is ...
05 Jan, 2022
Company names Christopher Beck as SVP, Operations and Mark Fletcher, Ph.D., as VP, R&DPHILADELPHIA, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, today announced the appointments of Christopher Beck as SVP of Operations and Mark Fletcher, Ph.D., as VP of R&D. Context also announced the planned retirement of its current
04 Jan, 2022
PHILADELPHIA, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, today announced that Chief Executive Officer Martin Lehr will participate virtually in two investor conferences in January 2022. Details of the events are as follows: Biotech Showcase™ 2022: The company’s presentation will be available for on-demand viewing dur
29 Dec, 2021
09:06
FinancialContent
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares climbed 64.8% to close at $19.02 on Tuesday as traders circulated a social ...
28 Dec, 2021
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 64.6% to $18.99 as traders circulated a social media post on a ...
22 Dec, 2021
Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 31.7% to $2.41 after the company announced it was awarded a multiple ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips We've reached the halfway point of the week and we're starting it with an overview of the biggest pre-market stock movers for Wednesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...
Gainers BioRestorative Therapies, Inc.(NASDAQ: BRTX) rose 48.1% to $6.77 in pre-market trading after the company entered ...
14 Dec, 2021
10:15
FinancialContent
Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire ...
13 Dec, 2021
Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals ...
Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 32.6% to $3.58 in pre-market trading after gaining more than 14% on ...
10:21
FinancialContent
Gainers SigmaTron International, Inc. (NASDAQ: SGMA) jumped 84.7% to settle at $14.94 on Friday after the company reported Q2 EPS ...
10 Dec, 2021
Gainers American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT) jumped 43.1% to $2.6909. American Virtual Cloud Technologies ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Oracle (ORCL) stock is on the rise Friday thanks to the computer tech company's earnings report for its fiscal second quarter of 2022. The post ORCL Stock: 6 Reasons Why Oracle Investors Are Smiling Today appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips MeaTech3D (MITC) stock is heating up today following news of a major breakthrough in its efforts to create 3D-printed steak. The post MITC Stock: The Lab-Grown Steak Breakthrough That Has MeaTech3D Looking Tasty Today appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Context Therapeutics (CNTX) stock is rising higher on Friday thanks to results from a Phase 0 breast cancer clinical trial. The post CNTX Stock: The Breast Cancer Clinical Trial Data That Has Context Therapeutics Soaring Today appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...
Gainers Context Therapeutics Inc. (NASDAQ: CNTX) rose 48.6% to $9.30 in pre-market trading as the company announced data from ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! It's the last day of the trading week and we're starting it with the biggest pre-market stock movers for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...
Context Therapeutics Inc(NASDAQ: CNTX) posteddata from the window-of-opportunity trialof onapristone extended-release ...
09:16
FinancialContent
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares jumped 84% to close at $4.95 on Thursday after the company ...
09 Dec, 2021
08:07
FinancialContent
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares surged 84.1% to close at $19.11 on Wednesday. Insignia Systems recently ...
08 Dec, 2021
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 79% to $18.63. Insignia Systems recently announced the commencement ...
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus EyePoint Announces ...
06 Dec, 2021
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt ...
03 Dec, 2021
10:04
FinancialContent
Gainers Jowell Global Ltd.(NASDAQ: JWEL) jumped 25.5% to close at $13.36. Jowell Global recently announced a collaboration ...
02 Dec, 2021
Toward the end of trading Thursday, the Dow traded up 1.84% to 34,649.26 while the NASDAQ rose 0.61% to 15,347.69. The S&P also ...
The Dow Jones Industrial Average is continuing to scrape together a solid rebound off yesterday's selloff, last seen up over 560 points. The S&P 500 and Nasdaq Composite are both higher as well
Midway through trading Thursday, the Dow traded up 1.37% to 34,488.64 while the NASDAQ rose 0.01% to 15,256.08. The S&P also rose, ...
Gainers Biofrontera Inc. (NASDAQ: BFRI) surged 39% to $6.02. Biofrontera announced Notice of Allowance for U.S. patent titled ...
Following the market opening Thursday, the Dow traded up 1.27% to 34,453.32 while the NASDAQ fell 0.01% to 15,252.20. The S&P also ...
Newly listedContext Therapeutics Inc(NASDAQ: CNTX) has announced aprivate placement of $31.25 million. The placement ...
01 Dec, 2021
Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) climbed 91.7% to $6.14 on above-average volume on Wednesday. The Patent Trial ...
Gainers Skylight Health Group Inc.(NASDAQ: SLHG) rose 55.3% to $2.05 in pre-market trading after dipping around 10% on ...
30 Nov, 2021
Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares jumped 105.9% to $4.53. The FDA approved expanded labeling for ...
Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) rose 117.3% to $4.78 in pre-market trading after the company announced the ...
22 Nov, 2021
09:53
FinancialContent
Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares surged 90.2% to close at $9.89 on Friday. Greenland ...
19 Nov, 2021
Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares jumped 75.4% to $9.17. Greenland Technologies ...
01 Nov, 2021
21:53
Seeking Alpha
02 Jul, 2021

Related Articles